<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00739531</url>
  </required_header>
  <id_info>
    <org_study_id>CP00014</org_study_id>
    <nct_id>NCT00739531</nct_id>
  </id_info>
  <brief_title>Measuring Exhaled Nitric Oxide (eNO) Using the Apieron INSIGHT System and the Aerocrine NIOX System</brief_title>
  <official_title>Measuring the Fractional Concentration of Exhaled Nitric Oxide (eNO) Using the Apieron INSIGHT System and the Aerocrine NIOX System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Apieron</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Apieron</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Collection of quantitative data to demonstrate the accuracy (bias) and precision
      (repeatability) of the Apieron INSIGHT(tm) eNO Breath System as compared to the FDA cleared
      NIOX eNO Breath System when testing is performed by asthma patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A non-randomized, prospective study of up to 150 subjects with asthma. Patients will perform
      eNO testing with the Apieron INSIGHT(tm) eNO system and the NIOX eNO system at the
      physician's office/clinic after a short demonstration and training by a healthcare
      professional trained in the use of the devices. Exhaled NO testing involves inhaling to lung
      capacity, and then performing a controlled exhalation into a mouthpiece connected to each of
      the Apieron INSIGHT(tm) and NIOX systems. Patients will perform an eNO measurement with the
      Apieron INSIGHT(tm) system and with the FDA cleared NIOX system for the accuracy portion of
      the study. Patients will perform 2 sequential eNO measurements on each system for the
      precision part of the study. Subjects that measure eNO values over 100 ppb will be asked to
      repeat 2 sequential eNO measurements on each system.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>eNO using Apieron INSIGHT(tm) System and Aerocrine NIOX at 50 ml/s</measure>
    <time_frame>Single point in time</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Asthmatics</arm_group_label>
    <description>Subjects with asthma</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Exhaled nitric oxide (eNO)</intervention_name>
    <description>Subjects will perform a controlled breath maneuver using both the Apieron and NIOX devices. The devices will measure nitric oxide in the subjects' exhaled breath.</description>
    <arm_group_label>Asthmatics</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Up to 150 asthma patients recruited from the site center's population of patients.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 5 or older

          -  Pre-existing diagnosis of asthma

          -  Non-smoker

        Exclusion Criteria:

          -  Chronic inflammatory lung disease other than asthma

          -  Medical conditions that preclude hand-eye coordination
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Asthma- Allergy Clinic&amp; Research Center</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allergy, Asthma &amp; Dermatology Research Center, LLC</name>
      <address>
        <city>Lake Oswego</city>
        <state>Oregon</state>
        <zip>97035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2008</study_first_submitted>
  <study_first_submitted_qc>August 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2008</study_first_posted>
  <last_update_submitted>August 20, 2008</last_update_submitted>
  <last_update_submitted_qc>August 20, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2008</last_update_posted>
  <responsible_party>
    <name_title>Nina Peled, VP of Regulatory and Clinical Affairs</name_title>
    <organization>Apieron</organization>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>nitric oxide</keyword>
  <keyword>eNO</keyword>
  <keyword>FENO</keyword>
  <keyword>Apieron INSIGHT</keyword>
  <keyword>Aerocrine NIOX</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitric Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

